SBC

SBC Medical Group Holdings Incorporated · NASDAQ · Industrials · USD · 10-K for 2025, filed 2026-03-27

Figures on this page computed 2026-11-08 12:57 UTC

Last close

5.32USD

Market data, 2026-11-04

SBC: weekly closes from 3.66 on 2026-08-14 to 5.32 on 2026-11-04, a move of +45.4%. Prices in USD.

Weekly closes, 2026-08-14 to 2026-11-04

Over that span: +45.4%

Except where said otherwise: 10-K for 2025, filed 2026-03-27

10.1xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-27
The filing itself
30.8%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-13
The filing itself
29.4%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
The filing itself
13.4%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
The filing itself
0.21Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-13
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

0.93x

1.42x

1.59x

2.38x

0.69x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-03-27

Sales0.93x
Its own average over 4 years, 186.7M.
Profit1.42x
Its own average over 4 years, 35.8M.
Free cash flow1.59x
Its own average over 4 years, 14.6M.
Debt2.38x
Its own average over 4 years, 21.8M.
Price0.69x
Its own average over 5 years, 8. Market data, 2026-11-04

Debt is furthest from its own average, at 2.38 times.

The filed years, as a table

Each line is 100 at 2022-12-31, the first year we hold.

Filed year	Sales	Profit	Shares in issue
2022-12-31	100.0	100.0	100.0
2023-12-31	111.1	623.4	625.2
2024-12-31	117.9	738.2	640.9
2025-12-31	99.7	807.4	683.6

How sales was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001193125-26-127557
Reported in: USD

The filing itself

How profit was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001193125-26-127557
Reported in: USD

The filing itself

How shares in issue was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001193125-26-127557
Reported in: USD

The filing itself

Figures behind the shape

Growth

9.4%

faster is higher, placed against 4,950 companies as of 2026-11-07

Five-year revenue growth raten/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
One-year change in net income9.4%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Returns on capital

30.8%

higher is higher, placed against 5,089 companies as of 2026-11-07

Return on invested capital30.8%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-13
The filing itself
Return on equity20.5%
Net Income / Shareholders' Equity x 100
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-13
The filing itself
Return on assets13.4%
Net Income / Total Assets x 100
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-13
The filing itself

Margins

73.3%

wider is higher, placed against 3,412 companies as of 2026-11-07

Gross margin73.3%
Gross Profit / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
The filing itself
Operating margin38.9%
Operating Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
The filing itself
Net margin29.4%
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
The filing itself
Free cash flow margin13.4%
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
The filing itself

Price

10.1x

cheaper is higher, placed against 4,362 companies as of 2026-11-07

Price to earnings10.1x
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-27
The filing itself
Price to book2.1x10-Q for 2025, filed 2026-08-13
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Fiscal year
2025
Accession
0001193125-26-347843
Reported in
USD
- computed
- 10-Q for 2025, filed 2026-08-13
- computed
- 10-K for 2025, filed 2026-03-27
The filing itself
EV to EBITDA5.8x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-27
The filing itself
Price to sales ratio3.0x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
The filing itself

Safety

0.21

safer is higher, placed against 3,227 companies as of 2026-11-07

Debt to equity0.21
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-13
The filing itself
Current ratio3.7810-Q for 2025, filed 2026-08-13
Current Assets / Current Liabilities
Source
computed
Fiscal year
2025
Accession
0001193125-26-347843
Reported in
USD
- 10-Q for 2025, filed 2026-08-13
- 10-Q for 2025, filed 2026-08-13
The filing itself
Interest coverage455.3x
Operating Income / Interest Expense
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
The filing itself
Altman Z-Score5.12
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
USD
- Computed from the 10-K for 2025, filed 2026-03-27
- Computed from the 10-K for 2025, filed 2026-03-27
- Computed from the 10-K for 2025, filed 2026-03-27
- Computed from the 10-K for 2025, filed 2026-03-27
- Computed from the 10-K for 2025, filed 2026-03-27

What it pays out

n/a

We do not hold this figure for this company, so there is nothing to place.

more, and better covered, is higher, with no cohort held

Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- Computed from the 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
The filing itself
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.